Status:

NOT_YET_RECRUITING

Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer

Lead Sponsor:

Fudan University

Conditions:

Rectal Cancer

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

In this study, patients with middle or low rectal cancer will receive robotic radical resection, and will be randomly assigned to receive inferior mesenteric artery lymph nodes dissection or preservat...

Detailed Description

The goal of this clinical trial is to compare the outcomes of preserving versus dissecting inferior mesenteric artery root lymph nodes (IMA-LN) during robotic radical resection for mid/low rectal canc...

Eligibility Criteria

Inclusion

  • Age \>18 years and ≤80 years
  • Pathologically confirmed rectal adenocarcinoma by colonoscopic biopsy
  • Tumor located ≤10 cm from the anal verge
  • No metastasis at the root of the inferior mesenteric artery (IMA) and no lateral lymph node metastasis confirmed by pelvic ultrasound, contrast-enhanced CT, and/or PET-CT (diagnostic criteria per the 2024 Chinese Society of Clinical Oncology \[CSCO\] Guidelines)
  • No distant metastasis (including pelvic, peritoneal, hepatic, pulmonary, cerebral, skeletal, or distant lymph node metastasis) confirmed by imaging
  • Pelvic MRI and/or transrectal ultrasound confirming cT1-T3 N0-1 stage, or ycT1-T3 Nx after neoadjuvant therapy (radiotherapy, chemotherapy, immunotherapy, targeted therapy)
  • No history of other malignancies (except adequately treated basal cell carcinoma or cervical carcinoma in situ)
  • Suitable for robotic surgery
  • Signed informed consent

Exclusion

  • Clinical complete response after radiotherapy, chemotherapy, immunotherapy, or targeted therapy
  • cT1N0 tumors suitable for local excision
  • Emergency surgery required due to acute bowel obstruction, hemorrhage, or perforation
  • Multiple primary colorectal malignancies
  • Familial adenomatous polyposis (FAP), Lynch syndrome, or inflammatory bowel disease
  • Concomitant conditions requiring concurrent colonic resection
  • American Society of Anesthesiologists (ASA) grade \>III
  • Pregnancy or lactation
  • Preoperative short-course radiotherapy
  • Inability of the patient/family to comprehend the study protocol

Key Trial Info

Start Date :

June 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2031

Estimated Enrollment :

1596 Patients enrolled

Trial Details

Trial ID

NCT06956976

Start Date

June 1 2025

End Date

June 1 2031

Last Update

May 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zhongshan Hospital Fudan University

Shanghai, Shanghai Municipality, China, 200032

Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer | DecenTrialz